Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

Stock Information for Delcath Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Delcath Systems Inc.

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.